Advertisement
Screener

BIOTRICITY INC. (BTCY) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum

BIOTRICITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum

BIOTRICITY INC. (BTCY) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 3.01% for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2023-08-14

  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2023-06-30 was 3.01%.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2021-06-30 was 1.70%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month as first filed
2023-06-303.01%
10-Q · filed 2023-08-14
2021-06-301.70%
10-Q/A · filed 2021-08-17
2021-03-311.72%
10-Q/A · filed 2021-08-17
0.00%
10-K · filed 2021-06-22
2020-03-312.81%
10-Q/A · filed 2021-08-17
2019-03-312.81%
10-Q/A · filed 2021-08-17
2015-12-311.07%
8-K · filed 2016-04-13